Ono Pharmaceutical Co., Ltd. (OPHLY)
5.09
-0.02
(-0.39%)
USD |
OTCM |
Aug 24, 16:00
Ono Pharmaceutical Net Income (Quarterly) : 151.63M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 151.63M |
| March 31, 2026 | 6.635M |
| December 31, 2025 | 187.50M |
| September 30, 2025 | 151.60M |
| June 30, 2025 | 121.96M |
| March 31, 2025 | -41.78M |
| December 31, 2024 | 97.69M |
| September 30, 2024 | 112.65M |
| June 30, 2024 | 159.37M |
| March 31, 2024 | 117.39M |
| December 31, 2023 | 244.02M |
| September 30, 2023 | 295.39M |
| June 30, 2023 | 231.35M |
| March 31, 2023 | 129.05M |
| December 31, 2022 | 236.07M |
| September 30, 2022 | 237.94M |
| June 30, 2022 | 227.42M |
| March 31, 2022 | 137.69M |
| December 31, 2021 | 161.22M |
| September 30, 2021 | 201.90M |
| June 30, 2021 | 220.37M |
| March 31, 2021 | 84.48M |
| December 31, 2020 | 255.02M |
| September 30, 2020 | 172.93M |
| June 30, 2020 | 200.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 72.55M |
| December 31, 2019 | 175.39M |
| September 30, 2019 | 154.04M |
| June 30, 2019 | 149.02M |
| March 31, 2019 | 76.87M |
| December 31, 2018 | 127.06M |
| September 30, 2018 | 122.28M |
| June 30, 2018 | 139.71M |
| March 31, 2018 | 81.79M |
| December 31, 2017 | 179.39M |
| September 30, 2017 | 85.46M |
| June 30, 2017 | 106.21M |
| March 31, 2017 | 118.48M |
| December 31, 2016 | 177.08M |
| September 30, 2016 | 92.67M |
| June 30, 2016 | 126.99M |
| March 31, 2016 | 51.32M |
| December 31, 2015 | 60.51M |
| September 30, 2015 | 20.21M |
| June 30, 2015 | 77.74M |
| March 31, 2015 | -21.90M |
| December 31, 2014 | 106.66M |
| September 30, 2014 | 3.891M |
| June 30, 2014 | 29.06M |
| March 31, 2014 | 9.245M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Astellas Pharma, Inc. | 889.54M |
| Eisai Co., Ltd. | 120.18M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 728.94M |
| Total Expenses (Quarterly) | 577.39M |
| EPS Diluted (Quarterly) | 0.1075 |
| Enterprise Value | 6.571B |
| Gross Profit Margin (Quarterly) | 75.31% |
| Profit Margin (Quarterly) | 20.80% |
| Earnings Yield | 6.91% |